SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

The US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption ...

The following is a summary of "Impact of sodium-glucose cotransporter‐2 inhibitors in patients with recent versus previous ...

In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.

De-escalating dual antiplatelet therapy from from aspirin plus ticagrelor to aspirin plus clopidogrel after primary ...

A new clinical trial finds no cardiovascular benefit from high-dose multivitamins, with or without chelation therapy, in ...

The following is a summary of "Low-dose dobutamine stress myocardial contrast echocardiography for evaluating myocardial ...

For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual sodium ...

Highlights include new evidence on intracoronary imaging and the first inclusion of a mechanical circulatory support device ...